Surgery Partners (SGRY) Expected to Announce Earnings on Tuesday

Key Points

• Surgery Partners (SGRY) is set to release its Q2 2025 earnings on August 5th, with analysts expecting earnings of $0.16 per share and revenue of $816.96 million.
• The company's last quarterly earnings report showed a net margin of -6.10% and revenue growth of 8.2% year-over-year but missed estimates, indicating mixed financial health.
• Despite recent performance, a number of analysts have issued a "buy" rating for SGRY, with price targets ranging from $24.00 to $35.00, reflecting positive investor sentiment.

Surgery Partners (NASDAQ:SGRY - Get Free Report) is anticipated to release its Q2 2025 earnings data before the market opens on Tuesday, August 5th. Analysts expect Surgery Partners to post earnings of $0.16 per share and revenue of $816.96 million for the quarter. Surgery Partners has set its FY 2025 guidance at EPS.

Surgery Partners (NASDAQ:SGRY - Get Free Report) last released its earnings results on Monday, May 12th. The company reported $0.04 EPS for the quarter, missing analysts' consensus estimates of $0.08 by ($0.04). Surgery Partners had a negative net margin of 6.10% and a positive return on equity of 2.41%. The firm had revenue of $776.00 million during the quarter, compared to the consensus estimate of $777.77 million. During the same period in the prior year, the company earned $0.10 EPS. The firm's revenue was up 8.2% compared to the same quarter last year. On average, analysts expect Surgery Partners to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Surgery Partners Trading Down 3.1%

Shares of SGRY stock traded down $0.67 on Friday, hitting $21.28. 3,103,577 shares of the company's stock traded hands, compared to its average volume of 1,380,356. The company has a debt-to-equity ratio of 1.09, a quick ratio of 1.73 and a current ratio of 1.89. Surgery Partners has a one year low of $18.87 and a one year high of $33.97. The company's fifty day simple moving average is $22.22 and its 200 day simple moving average is $22.85. The stock has a market capitalization of $2.73 billion, a price-to-earnings ratio of -13.91 and a beta of 1.90.

Institutional Investors Weigh In On Surgery Partners

Large investors have recently bought and sold shares of the business. Empowered Funds LLC increased its holdings in Surgery Partners by 11.0% during the 1st quarter. Empowered Funds LLC now owns 12,853 shares of the company's stock worth $305,000 after purchasing an additional 1,278 shares during the period. Millennium Management LLC lifted its holdings in shares of Surgery Partners by 1,253.7% during the first quarter. Millennium Management LLC now owns 202,274 shares of the company's stock worth $4,804,000 after purchasing an additional 219,806 shares during the period. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its holdings in shares of Surgery Partners by 4.6% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 45,693 shares of the company's stock valued at $1,085,000 after purchasing an additional 2,015 shares in the last quarter.

Wall Street Analysts Forecast Growth

A number of research analysts have issued reports on SGRY shares. Benchmark reissued a "buy" rating and set a $35.00 price objective on shares of Surgery Partners in a research report on Monday, April 21st. Barclays lowered their price target on shares of Surgery Partners from $25.00 to $24.00 and set an "equal weight" rating for the company in a research report on Tuesday, May 27th. Finally, Bank of America initiated coverage on shares of Surgery Partners in a research note on Monday. They set a "buy" rating and a $28.00 price objective for the company. One analyst has rated the stock with a sell rating, three have assigned a hold rating and seven have issued a buy rating to the company's stock. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average target price of $33.33.

About Surgery Partners

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.